NCT04157374

Brief Summary

The study is a single-blind controlled randomized clinical trial.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 8, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2021

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

September 16, 2021

Status Verified

September 1, 2021

Enrollment Period

1.6 years

First QC Date

August 6, 2019

Last Update Submit

September 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of disability of patients

    Change in Oswestry Disability Index (ODI-I). Range: 0 (lower disability), 50 (higher disability)

    Patients will be evaluated before the treatment (T0), three weeks after the beginning (T1) and 4 months upon the end of it (T2)

Secondary Outcomes (3)

  • Pain of patients

    Patients will be evaluated before the treatment (T0), three weeks after the beginning (T1) and 4 months upon the end of it (T2)

  • Quality of life of patients

    Patients will be evaluated before the treatment (T0), three weeks after the beginning (T1) and 4 months upon the end of it (T2)

  • fear of movement of patients

    Patients will be evaluated before the treatment (T0), three weeks after the beginning (T1) and 4 months upon the end of it (T2)

Study Arms (2)

EXPERIMENTAL GROUP

EXPERIMENTAL

AOT and Active exercises

Other: Action Observation trainingOther: Active Exercises

Control group

ACTIVE COMPARATOR

Active exercises

Other: Active Exercises

Interventions

They have to watch a video showing a person carrying out exercises (12 exercises: 3 of stretching, 3 of core stability, 3 of mobilization and 3 of functional). then they have to practice them. The observation of the exercises and their performance last 8 minutes (4 minutes for observation and 4 minutes for practice). They have to repeat the exercises 5 times per week for 3 weeks.

Also known as: AOT
EXPERIMENTAL GROUP

Execution of exercises: 3 of stretching, 3 of core stability, 3 of mobilization and 3 of functional activity. Patients of the control group recieve a brochure with the same exercises the patients of the experimental group received through the video. They will be asked to read the exercise 3 times and to practice it for 4 minutes. They have to repeat the exercises 5 times per week for 3 weeks.

Control groupEXPERIMENTAL GROUP

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients with chronic aspecific LBP (documented story of more than 12 week-long symptomatology)
  • Good understanding of Italian language
  • Aged over 65

You may not qualify if:

  • Severe sight or hearing impairement
  • Cognitive deficit (assessed by a Mini Mental State Examination score ≤21 \[14\]).
  • Specific LBP (previous spine surgery, deformation, infection, fracture, malignant tumor, general disorders or neuromuscular pathologies)
  • Patients who previously experimented AOT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roberto Gatti

Rozzano, Milan, 20089, Italy

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Physiotherapy

Study Record Dates

First Submitted

August 6, 2019

First Posted

November 8, 2019

Study Start

May 29, 2019

Primary Completion

January 10, 2021

Study Completion

July 30, 2022

Last Updated

September 16, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations